22-39317633-C-CA
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_000967.4(RPL3):c.197-5_197-4insT variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000468 in 1,551,016 control chromosomes in the GnomAD database, including 1 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00038 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00048 ( 1 hom. )
Consequence
RPL3
NM_000967.4 splice_region, splice_polypyrimidine_tract, intron
NM_000967.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.858
Genes affected
RPL3 (HGNC:10332): (ribosomal protein L3) Ribosomes, the complexes that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L3P family of ribosomal proteins and it is located in the cytoplasm. The protein can bind to the HIV-1 TAR mRNA, and it has been suggested that the protein contributes to tat-mediated transactivation. This gene is co-transcribed with several small nucleolar RNA genes, which are located in several of this gene's introns. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 22-39317633-C-CA is Benign according to our data. Variant chr22-39317633-C-CA is described in ClinVar as [Benign]. Clinvar id is 781529.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 57 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPL3 | NM_000967.4 | c.197-5_197-4insT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000216146.9 | NP_000958.1 | |||
RPL3 | NM_001033853.2 | c.197-5_197-4insT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001029025.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPL3 | ENST00000216146.9 | c.197-5_197-4insT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000967.4 | ENSP00000346001 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000379 AC: 57AN: 150228Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
57
AN:
150228
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000478 AC: 669AN: 1400678Hom.: 1 Cov.: 31 AF XY: 0.000518 AC XY: 361AN XY: 696620
GnomAD4 exome
AF:
AC:
669
AN:
1400678
Hom.:
Cov.:
31
AF XY:
AC XY:
361
AN XY:
696620
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000379 AC: 57AN: 150338Hom.: 0 Cov.: 32 AF XY: 0.000423 AC XY: 31AN XY: 73372
GnomAD4 genome
AF:
AC:
57
AN:
150338
Hom.:
Cov.:
32
AF XY:
AC XY:
31
AN XY:
73372
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at